CRESTEC Inc. engages in the document business in Japan and internationally. It offers various services for manual creation, including writing, translation, and desktop publishing. The company also provides market research, consulting, planning, development, writing, data creation, localization, packaging design, printing/production, and aftermarket support, as well as law document support and international standards information sections. Crestec Inc. was incorporated in 1984 and is headquartered in Hamamatsu, Japan.

CRESTEC Inc.

Machine Translation utilizes computational biology, novel Machine Learning & AI, bioinformatic simulations, and a unique data set to determine which drug candidates will most likely succeed in clinical studies.

Machine Translation

株式会社クレステック is described as an 'information creation company' that connects people and objects through communication, creating forms for the information that needs to be conveyed.

Metric
Company Name	CRESTEC Inc.	Machine Translation
Symbol	7.81K
MSH ID	JP:CO:CRESTEC	COM:MACHTRANSPRO
Market	STOCKS	PRIVATE
Sector	Industrials	Healthcare & Health Services
Industry	Specialty Business Services	Biotechnology
Country	JP	US
Stage
Employee Count	1.43K
Website	crestec.co.jp	machtranspro.com
LinkedIn	crestec-inc-
Founders

Metric
Market Cap	34.94M
Enterprise Value
Monthly Web Traffic	324	162.88K
Web Traffic Growth	-0.91	-0.34
Valuation
Raised Capital

Metric
Revenue	127.16M
Revenue (LTM)
Revenue (NTM)
Gross Profit	34.87M
EBITDA	13.73M
Operating Income	7.88M
Net Income	6.07M
EPS	1.97
Diluted EPS	1.97
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.28
Operating Profit Margin	0.06
EBITDA Margin	0.11
Net Profit Margin	0.05
Return on Equity	0.12
Return on Assets	0.05
Return on Capital Employed	0.10

7812

JP:CO:CRESTEC

株式会社クレステック

Last Close

1,512.00

25/11 06:45

Market Cap

5.24B

Beta: -

Volume Today

6.30K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	6.83
P/B Ratio	0.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.28
EV Multiple	2.22

Metric
Days Sales Outstanding	66.59
Days Payables Outstanding	31.78
Days Inventory Outstanding	46.17
Operating Cycle	109.07
Cash Conversion Cycle	77.29
Asset Turnover	0.99

Metric
Operating Cash Flow	16.58M
Free Cash Flow	10.93M
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents	37.90M
Accounts Receivable	3.37M
Inventory	11.51M
Goodwill	573.48K
Debt to Capitalization	0.49
Debt to Assets	0.38
Current Ratio	1.62
Quick Ratio	1.43

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.00
SG&A to Revenue